Liu Feng-Jie, Yang Jiao, Chen Xu-Yan, Yu Ting, Ni Hui, Feng Liang, Li Ping, Li Hui-Jun
State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China.
Chin Med. 2022 Nov 4;17(1):125. doi: 10.1186/s13020-022-00679-4.
Dandelion is an herb with high nutritional and medicinal values, which has been listed in Chinese Pharmacopeia, European Pharmacopoeia and British Pharmacopoeia, gaining increasing acceptance around the world. However, the current quality control of dandelion is lagging behind. Only in Chinese Pharmacopeia, cichoric acid is used as a marker compound for its quality evaluation, whereas, it can not comprehensively reflect the bioactivity of dandelion.
This study developed a strategy by integrating chemometrics with in silico pharmacology to reveal the bioactive markers of dandelion for its quality control. Firstly, the major chemicals in dandelion were characterized using HPLC-DAD-MS/MS, and the corresponding antioxidant and anti-inflammatory activities were evaluated in vitro. Subsequently, the active components were screened by relating the chemicals and bioactivity of dandelion via grey relational assay and partial least squares regression analysis. The potential active components were then subjected to a validation for their activities. Moreover, in silico pharmacology was utilized to evaluate the contribution of active components to efficacy.
A total of 22 phenolic compounds were characterized. Among them, cichoric acid, caffeic acid and luteolin were identified as quality markers owing to their good correlations with the bioactivities of dandelion. These three markers were quantified in frequently-used dandelion species, viz. Taraxacum mongolicum Hand.-Mazz. (TAM) and T. officinale F. H. Wigg. (TAO). TAM, with acceptably higher content of cichoric acid and caffeic acid, showed better antioxidant activity than TAO. While TAO included higher content of luteolin, presenting slightly more effective in anti-inflammation.
An useful strategy for the quality marker discovery was successfully designed. And the results provided more knowledge for the quality evaluation of dandelion.
蒲公英是一种具有高营养价值和药用价值的草药,已被列入《中国药典》《欧洲药典》和《英国药典》,在全球范围内越来越受到认可。然而,目前蒲公英的质量控制较为滞后。仅在《中国药典》中,以菊苣酸作为其质量评价的指标性成分,而这无法全面反映蒲公英的生物活性。
本研究开发了一种将化学计量学与计算机模拟药理学相结合的策略,以揭示蒲公英用于质量控制的生物活性指标成分。首先,采用高效液相色谱 - 二极管阵列 - 串联质谱法(HPLC-DAD-MS/MS)对蒲公英中的主要化学成分进行表征,并在体外评估其相应的抗氧化和抗炎活性。随后,通过灰色关联分析和偏最小二乘回归分析,将蒲公英的化学成分与生物活性相关联,筛选出活性成分。然后对潜在的活性成分进行活性验证。此外,利用计算机模拟药理学评估活性成分对药效的贡献。
共鉴定出22种酚类化合物。其中,菊苣酸、咖啡酸和木犀草素因其与蒲公英生物活性的良好相关性而被确定为质量指标成分。在常用的蒲公英品种,即蒙古蒲公英(Taraxacum mongolicum Hand.-Mazz.,TAM)和药用蒲公英(T. officinale F. H. Wigg.,TAO)中对这三种指标成分进行了定量分析。TAM中菊苣酸和咖啡酸含量较高,其抗氧化活性优于TAO。而TAO中木犀草素含量较高,在抗炎方面表现稍好。
成功设计了一种用于发现质量指标成分的有效策略。研究结果为蒲公英的质量评价提供了更多知识。